Elpis Biopharmaceuticals
PrivateLast Round
Series A
Oct 29, 2020
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elpis Biopharmaceuticals operates in Healthcare & Life Sciences and is based in Lexington, Massachusetts. Its latest recorded funding round was a Series A round in October 2020.
Elpis Biopharmaceuticals is a biopharmaceutical company that develops next-generation multifunctional immunotherapies to transform cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elpis Biopharmaceuticals Comparables
Compare Elpis Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A2 Biotherapeutics | 81% | |
| ArsenalBio | 81% | |
| Mustang Bio Inc | 80% |
For institutional investors. Book with your work email.
Elpis Biopharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 5, representing 45% of headcount.
- Jun 23, 2026
Monthly visitors increased 3342% MoM, reaching 15K.
For institutional investors. Book with your work email.
Elpis Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elpis Biopharmaceuticals's valuation, stock price, and market status.
Is Elpis Biopharmaceuticals a public or private company?
Elpis Biopharmaceuticals is a private company.
What is the current stock price of Elpis Biopharmaceuticals?
Elpis Biopharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Elpis Biopharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elpis Biopharmaceuticals worth (valuation)?
Valuation information for Elpis Biopharmaceuticals is not publicly available.
Can I buy Elpis Biopharmaceuticals stock?
Elpis Biopharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elpis Biopharmaceuticals's last funding round?
Elpis Biopharmaceuticals's most recent funding round was Series A on October 29, 2020.
Who are the main investors in Elpis Biopharmaceuticals?
Investor information for Elpis Biopharmaceuticals is not publicly disclosed.
Will Elpis Biopharmaceuticals IPO soon?
No public IPO plans have been announced for Elpis Biopharmaceuticals.
How can I track Elpis Biopharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Elpis Biopharmaceuticals's shares on secondary markets.